Boyu, Sinopharm among bidders shortlisted for Mundipharma China: sources

Stock Markets1 hour ago (Jun 08, 2021 03:55AM ET)

(C) Reuters. FILE PHOTO: Signage of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang

By Kane Wu

HONG KONG (Reuters) – Drugmaker Mundipharma has included Boyu Capital and state-owned Sinopharm on a shortlist of bidders for its Chinese business, two people familiar with the situation said.

Chinese buyout firms CITIC Capital and CPE are also on the shortlist for Mundipharma’s China unit, which sources have said could fetch more than $1 billion.

Mundipharma, which is owned by the billionaire American Sackler family, has chosen about half of around 20 initial possible buyers, including private equity firms and strategic players, to proceed to the next round, one of the people said.

Bids for the second round are non-binding and are due in July, the sources, who declined to be identified as the information is confidential, told Reuters.

A third person close to the situation said remaining bidders also included global and regional private equity firms.

Mundipharma and CPE declined to comment.

A spokesperson for Sinopharm said it could not comment as it did not have any relevant information on the transaction.

Boyu and CITIC Capital did not respond to Reuters queries.

Mundipharma, which is based in Cambridge, Britain, says it has a presence in 120 countries and $2 billion in global sales from drugs for pain management and supportive care, diabetes, oncology and respiratory diseases, among others.

Mundipharma launched in China, where its business now has more than 1,500 employees, in 1993 with a high-profile ceremony at the Great Hall of the People on Tiananmen Square.

Its Beijing factory is the biggest maker of narcotic and psychoactive drugs in the country, its website says, with the painkiller OxyContin one of the Chinese unit’s core products.

Deutsche Bank (DE:DBKGn) is advising Mundipharma on the sale, Reuters has previously reported. The German bank declined to comment.

Boyu, Sinopharm among bidders shortlisted for Mundipharma China: sources

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Stories

Discover

S&P 500 Struggles for Direction After Hitting Fresh Record;...

Stock Markets8 minutes ago (Jun 15, 2021 03:57PM ET) (C) Reuters. By Yasin Ebrahim Investing.com -...

Extra Crunch roundup: TC Mobility recaps, Nubank EC-1, farewell...

What, exactly, are investors looking for? Early-stage founders, usually first-timers, often tie themselves in knots...

All Eyes on Fed, Housing, Biden Meets the ‘Killer:’...

Stock Markets11 minutes ago (Jun 15, 2021 03:55PM ET) (C) Reuters. By Christiana Sciaudone Investing.com --...

Southwest Airlines temporarily halted flights over computer issue

Stock Markets15 minutes ago (Jun 15, 2021 03:50PM ET) (C) Reuters. FILE PHOTO: A Southwest...

U.S. Oil Closes at 2018 High Amid Hopes of...

Commodities17 minutes ago (Jun 15, 2021 03:48PM ET) (C) Reuters. By Barani Krishnan Investing.com - U.S....

Chinese startup Pony.ai plans to launch a driverless robotaxi...

Pony.ai, the robotaxi startup that operates in China and the United States, has started...

Popular Categories